Related Experiment Video
Updated: May 22, 2026

Intratracheal Instillation of Stem Cells in Term Neonatal Rats
Published on: May 4, 2020
Early CPAP versus surfactant in extremely preterm infants
Insights
Continuous positive airway pressure (CPAP) offers an alternative to early surfactant treatment for extremely-low-birth-weight infants. This approach reduces the need for intubation and mechanical ventilation, supporting preterm infant respiratory care.
Area of Science:
- Neonatal Medicine
- Respiratory Care
- Pediatric Critical Care
Background:
- Limited data exist comparing early continuous positive airway pressure (CPAP) versus early surfactant treatment for extremely-low-birth-weight (ELBW) infants.
- Choosing initial respiratory support for ELBW infants remains a clinical challenge.
Purpose of the Study:
- To compare the efficacy of early CPAP versus early surfactant treatment as initial respiratory support in ELBW infants.
- To evaluate the impact of these strategies on major neonatal outcomes, including death and bronchopulmonary dysplasia.
Main Methods:
- A randomized, multicenter, 2x2 factorial trial involving infants born between 24 and 27 weeks 6 days gestation.
- Infants were assigned to either intubation and surfactant treatment or CPAP initiated in the delivery room.
- A secondary randomization involved target oxygen saturation ranges.
Main Results:
- The primary outcome (death or bronchopulmonary dysplasia) did not differ significantly between the CPAP and surfactant groups (47.8% vs. 51.0%).
- CPAP use was associated with significantly less need for intubation, postnatal corticosteroids, and fewer days of mechanical ventilation.
- Infants receiving CPAP were more likely to be alive and free from mechanical ventilation by day 7.
Conclusions:
- CPAP is a viable alternative to intubation and surfactant treatment for preterm infants.
- Early CPAP initiation may reduce the need for invasive ventilation and associated complications in ELBW infants.
Background:
There are limited data to inform the choice between early treatment with continuous positive airway pressure (CPAP) and early surfactant treatment as the initial support for extremely-low-birth-weight infants.
Methods:
We performed a randomized, multicenter trial, with a 2-by-2 factorial design, involving infants who were born between 24 weeks 0 days and 27 weeks 6 days of gestation. Infants were randomly assigned to intubation and surfactant treatment (within 1 hour after birth) or to CPAP treatment initiated in the delivery room, with subsequent use of a protocol-driven limited ventilation strategy. Infants were also randomly assigned to one of two target ranges of oxygen saturation. The primary outcome was death or bronchopulmonary dysplasia as defined by the requirement for supplemental oxygen at 36 weeks (with an attempt at withdrawal of supplemental oxygen in neonates who were receiving less than 30% oxygen).
Results:
A total of 1316 infants were enrolled in the study. The rates of the primary outcome did not differ significantly between the CPAP group and the surfactant group (47.8% and 51.0%, respectively; relative risk with CPAP, 0.95; 95% confidence interval [CI], 0.85 to 1.05) after adjustment for gestational age, center, and familial clustering. The results were similar when bronchopulmonary dysplasia was defined according to the need for any supplemental oxygen at 36 weeks (rates of primary outcome, 48.7% and 54.1%, respectively; relative risk with CPAP, 0.91; 95% CI, 0.83 to 1.01). Infants who received CPAP treatment, as compared with infants who received surfactant treatment, less frequently required intubation or postnatal corticosteroids for bronchopulmonary dysplasia (P<0.001), required fewer days of mechanical ventilation (P=0.03), and were more likely to be alive and free from the need for mechanical ventilation by day 7 (P=0.01). The rates of other adverse neonatal outcomes did not differ significantly between the two groups.
Conclusions:
The results of this study support consideration of CPAP as an alternative to intubation and surfactant in preterm infants. (ClinicalTrials.gov number, NCT00233324.)
More Related Videos
04:56Laryngeal Mask Airway (LMA) Placement in a Neonatal Patient Simulator Using a Non-Inflatable Supraglottic Airway (SGA)
Published on: July 14, 2023
07:15Preoxygenation Techniques for Tracheal Intubation in Critically Ill Adults Utilizing Oxygen Mask and Noninvasive Ventilation
Published on: December 5, 2025
Related Concept Videos
Breathing
Assessment of Diffusion and Perfusion
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this principle...
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation (NIPPV)
Ventilatory Modes
There are three ventilatory modes: full support, partial support, and spontaneous. These are described below.
Full Support Modes
Full support modes include controlled mechanical ventilation, continuous mandatory...
Cardiopulmonary Resuscitation II: ACLS Airway Management